James McGorry (Insider Trades), president and CEO of Harvard Apparatus Regenerative Technology Inc. (HART, Financial), bought 10,000 shares of the company on Nov. 19. The price per share was $1.79 for a total transaction cost of $17,900. Harvard Apparatus Regenerative Technology is a biotechnology company that develops bioengineered organ implants for life-threatening conditions. The company has a market cap of $20.68 million and a P/S ratio of 155.35.
There were a total of 23 insider buys with Harvard Apparatus during 2015. McGorry made three of these transactions, the earliest in June. This transaction was of 30,000 shares of the company at an average per share price of $4.21, and the value has since decreased by about 60%. The company's month-end price has dropped by about 90% from July 2014 to July 2015, which correlates to a rise of insider buys during the same period of time. 
Harvard Apparatus CFO Thomas McNaughton (Insider Trades), bought 35,000 shares over three consecutive days starting on Nov. 17. The average price per share for each buy ranged from $1.32 to $1.70 per share. McNaughton’s earliest buy in February decreased in value by about 30% since then. For more information about insider transactions with Harvard Apparatus, click here.
The company reported net loss of $2.3 million, or 19 cents per share in the third quarter of 2015. Net income is up from a net loss of $2.7 million, or 34 cents per share reported in the corresponding quarter of 2014. The company attributed this increase to cutbacks of $200,000 in payroll-related costs, $200,000 in recruiting expenses, $100,000 in legal fees associated with intellectual property and $100,000 in other spending, offset by $200,000 in incremental spending related to animal studies. McGorry commented that the company made significant progress during the third quarter, due to the encouraging results of the company’s recent animal research study, which suggests that the company developed an implant that may restore the function of the esophagus. Annual revenue for the company follows an increasing trendline, while annual net income follows a decreasing trendline. 
On Nov. 10, the company received notice from the NASDAQ Stock Market LLC of a 180-day period in which to regain compliance with the requirement of at least a $1.00 minimum closing bid price for 30 consecutive days. Harvard Apparatus was able to reinstate their position within the deadline.
One guru made a transaction with the company during the third quarter of 2015. Jim Simons (Trades, Portfolio) increased his stake in the company by 45.61%, buying 48,799 shares at an average per share price of $1.13. In the previous quarter, Simons increased his holding by 618.13% at an average per share price of $2.45. The total estimated loss of the holding since the first quarter of 2015 is 19%. For more information about guru transactions with the company, click here.
For more stock trades of gurus in real time, visit GuruFocus’ Real Time Picks, a Premium Feature. Not a Premium Member of GuruFocus? Try it free for 7 days here.
